← Back to journals
ISJN: HLFIEiInternational Standard Journal Name (ISJN)
Open AccessDOAJ SealDOAJCrossrefOpenAlex

hLife

Metadata for this journal is being automatically enriched from connected scholarly data sources.

Journal information

Publisher
Elsevier
Subjects
Antibiotic Resistance in Bacteria · COVID-19 Clinical Research Studies · drugs · Gut microbiota and health · immunology · Immunotherapy and Immune Responses · interferon and immune responses · Medicine · Mosquito-borne diseases and control · pathogen biology · R · SARS-CoV-2 and COVID-19 Research · structural biology · translational medicine · vaccines · vaccines and immunoinformatics approaches
Country
NL
Languages
EN
ISSN
2949-9283
E-ISSN
2949-9283
ISSN-L
2949-9283
Open access
Yes
OA since
2023
Publication years
2023–2026
APC (summary)
Website
Visit journal ↗

Journal Classification

Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.

Classification
Field / Subfield
Primary Field
Medicine
Primary Subfield
Infectious Diseases
Domain
Health Sciences
Confidence
Low
Publications classified
132
Classification version
OAJF Classification v1.1

APC records

OPENALEX · 2026
2,150 EUR
OPENALEX · 2026
1,840 GBP
OPENALEX · 2026
285,270 JPY
OPENALEX · 2026
2,300 USD
DOAJ · 2026
2,300 USD